Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

rFSH

ApprovedSmall molecule

ZZekai Tahir Burak Women's Health Research and Education Hospital

rFSH is one of 25 small molecule programs targeting Ovarian Reserve. It is currently in Approved.

1

Indications

9

Total Trials

0

Active Trials

24

Competitors

Pipeline

Status by Indication[3][1]

Indication

Ovarian ReserveActive, not recruiting

Ovarian ReserveApproved

Active, not recruiting

Competition

Competitive Landscape

50 competitors in Ovarian Reserve

#DrugCompanyPhaseTrials

Ulipristal Acetate

Folvite

Circadin

NNeurim Pharmaceuticals Ltd.

Ovitrelle

Buserelin

NNCIC Clinical Trials Group

Human Menopausal Gonadotropin

Dehydroepiandrosterone

IInflabloc Pharmaceuticals

Trelstar

OOncoVerity, Inc.

Myoinositol

SSohag University

Dienogest

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Ovarian Stimulation1 trial

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

Completed·IInstituto Valenciano de Infertilidade de Lisboa·Phase 4·NCT03755973·24 enrolled

Frozen Embryo Transfer1 trial

Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer

Completed·LLG Chem··NCT05130125·1,166 enrolled

RFS1 trial

Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI

Completed·—·Phase 4·NCT02046655·80 enrolled

Ovarian Reserve1 trial

Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

Terminated·AAndros Day Surgery Clinic·Phase 4·NCT01816789·194 enrolled

Randomized Controlled Trial1 trial

Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist

Completed·HHospital de Clinicas de Porto Alegre·Phase 4·NCT02412904·188 enrolled

4 more indications

Controlled Ovarian Stimulation1 trial

Supplementation With Human Chorionic Gonadotropin (hCG) During Controlled Ovarian Stimulation With Recombinant Follicle-stimulating Hormone (FSH) for In Vitro Fertilisation

Completed·RRigshospitalet, Denmark·Phase 4·NCT00844311·60 enrolled

Intracytoplasmic Sperm Injection1 trial

Efficacy of Low Dose hCG on Oocyte Maturity in Poor Responder Women Undergoing Intracytoplasmic Sperm Injection

Completed·RRoyan Institute·Phase 3·NCT01509833·73 enrolled

Prevention1 trial

hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF

Completed·ZZekai Tahir Burak Women's Health Research and Education Hospital·Phase 4·NCT01365936·80 enrolled

Unspecified1 trial

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

Completed·YYazd Research & Clinical Center for Infertility·Phase 4·NCT00830492·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for rFSH. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — rFSH compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for rFSH. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Zekai Tahir Burak Women's Health Research and Education Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: ZZekai Tahir Burak Women's Health Research and Education Hospital

Related News